Medicare Enrolled
Dr. Alireza Nami, M.D.
Rheumatology · Charlotte, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nami from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nami?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nami
Dr. Alireza Nami is a rheumatology specialist in Charlotte, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nami performed 5,323 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nami received a total of $48,086 from 52 pharmaceutical and/or device companies across 753 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nami is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 5,323 Medicare services
$48,086 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,323
Medicare services
Bottom 48% in NC for rheumatology
Not available
Unique patients (not deduplicated)
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,763 | $18 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
615 | $91 | $200 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
453 | $54 | $150 |
| Methotrexate sodium, 50 mg | 308 | $2 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
169 | $0 | $12 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
141 | $56 | $193 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
122 | $8 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
118 | $98 | $300 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
112 | $64 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
70 | $11 | $100 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
58 | $9 | $40 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
53 | $5 | $24 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
47 | $122 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $62 | $160 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
36 | $31 | $150 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
35 | $25 | $33 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
31 | $21 | $35 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
28 | $25 | $51 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
26 | $25 | $150 |
| X-ray of upper spine, 2-3 views An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures. |
24 | $30 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $127 | $220 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
21 | $47 | $200 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
17 | $26 | $58 |
| New patient office visit, complex (60-74 min) | 17 | $163 | $280 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.6% high complexity
71.7% medium
25.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$48,086
Total received (2018-2024)
Avg $6,869/year across 7 years
Top 10% in NC for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
753
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$652
2023
$2,374
2022
$1,139
2021
$3,183
2020
$7,247
2019
$25,753
2018
$7,739
Payments by company (2024)
Amgen Inc.
$309
Novartis Pharmaceuticals Corporation
$71
ABBVIE INC.
$54
Lilly USA, LLC
$46
UCB, Inc.
$44
PFIZER INC.
$34
GlaxoSmithKline, LLC.
$24
Organon Llc
$19
Fresenius Kabi USA, LLC
$18
AstraZeneca Pharmaceuticals LP
$17
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 66.5% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Pharmaceuticals, Inc.
$12,260
Novartis Pharmaceuticals Corporation
$9,174
Horizon Therapeutics plc
$6,535
AstraZeneca Pharmaceuticals LP
$4,430
Amgen Inc.
$3,389
E.R. Squibb & Sons, L.L.C.
$2,335
AstraZeneca UK Limited
$1,586
Lilly USA, LLC
$942
UCB, Inc.
$912
GlaxoSmithKline, LLC.
$808
PFIZER INC.
$806
Regeneron Healthcare Solutions, Inc.
$678
Celgene Corporation
$675
AbbVie, Inc.
$634
Janssen Biotech, Inc.
$458
Antares Pharma, Inc.
$454
ABBVIE INC.
$209
Radius Health, Inc.
$159
Gilead Sciences, Inc.
$151
Hikma Pharmaceuticals USA
$116
Horizon Pharma plc
$108
Aurinia Pharma U.S., Inc.
$95
Janssen Scientific Affairs, LLC
$80
Genentech, Inc.
$80
Mallinckrodt Hospital Products Inc.
$75
Genentech USA, Inc.
$70
FIDIA PHARMA USA INC.
$64
Flexion Therapeutics, Inc.
$56
Bioventus LLC
$56
Takeda Pharmaceuticals U.S.A., Inc.
$54
West-Ward Pharmaceuticals
$52
AbbVie Inc.
$51
Mallinckrodt LLC
$48
Mallinckrodt Enterprises LLC
$44
GENZYME CORPORATION
$43
Avion Pharmaceuticals
$39
Ironwood Pharmaceuticals, Inc
$39
Zimmer Biomet Holdings, Inc.
$38
Vertical Pharmaceuticals, LLC
$29
Acella Pharmaceuticals, LLC
$27
Merck Sharp & Dohme Corporation
$26
MEDAC PHARMA, INC.
$24
SANOFI-AVENTIS U.S. LLC
$24
ASSERTIO THERAPEUTICS, Inc.
$22
Organon Llc
$19
Mylan Institutional Inc.
$19
Fresenius Kabi USA, LLC
$18
Sebela Pharmaceuticals Inc.
$17
Octapharma USA, Inc.
$17
Orthogenrx Inc.
$16
DePuy Synthes Sales Inc.
$15
MEDEXUS PHARMA, INC.
$11
Top 3 companies account for 58.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DUEXIS · DUZALLO · Durolane · EMBEDA · EVENITY · Enbrel · FORTEO · Gel-One Cross-linked Hyaluronate · GenVisc 850 · Gloperba · Gralise · HADLIMA · HUMIRA · Hulio · Humira · Hymovis · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LINZESS · LORZONE · LUPKYNIS · LYRICA · Mitigare · NP Thyroid · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OLUMIANT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · Prolia · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tymlos · Uloric · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
37
County median income
$83,765
Nearest hospital to ZIP centroid (approximate)
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nami is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nami experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Nami performed 2,763 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nami receive payments from pharmaceutical companies?
Yes. Dr. Nami received a total of $48,086 from 52 companies across 753 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nami's costs compare to other rheumatologists in Charlotte?
Dr. Nami's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nami) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Charlotte
Browse rheumatologists in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NC
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NC
Which NC rheumatologists receive the most from drug and device companies.
By company
Regeneron Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology